Post by
JohnnyYeg on Jan 15, 2025 11:18am
Expectations?
None. Every trial over the last 10 years has had "good safety data." Trial results - interim or later/final (BRACELET-1) - spark some results share price-wise but I only for a day or two.
The ONLY thing that will spark ANY kind of significant share price increase will be a biz dev announcement of a partnership or buyout. I'd be willing to bet a 50% CR from a trial would do little.
Big Pharma has done more with lesser advanced trials with other biotech devs than anything with ONC. For whatever reason, there seems to be little interest beyond curiosity with BP. Every single quarter ONC is meeting with these analysts, or hobnobbing with industry folk at that conference, or presenting posters there, with no results worth noting. Every. Single. Quarter.
We have a great - a fantastic - idea/product but no one else is excited about it. I mean what more do we need to show... to prove?
Yeah, I'm flabbergasted.
Comment by
Lesalpes29 on Jan 15, 2025 11:43am
Well said... uninterested BP at the moment. And ONC trying to survive... until... GL
Comment by
Buckhenry on Jan 15, 2025 1:07pm
I bet some of those folks that bought in pre market over a dollar are not happy campers!!
Comment by
Buckhenry on Jan 15, 2025 1:14pm
But since price does not matter i guess it's a moot point.
Comment by
Peladawn on Jan 15, 2025 1:08pm
Venture00zero....if the company was selling shares pre market by the multiple millions, why did the share price rise close to $1.20? One would think the share price would dive during the majority of your alleged "selling" activity.
Comment by
Peladawn on Jan 15, 2025 1:29pm
So you're saying whoever bought $30 million worth of shares this morning, wasn't smart enough to properly read the news release?
Comment by
CMHarring218431 on Jan 15, 2025 1:45pm
Johnny, like I said a couple of days ago..... any substantial news would be preceded by an increase in vol and price. Almost always! Gotta love Noteable's " en mass" claim . Again, I think he is very close to the company and that declaration of his was made to bolster and increase speculation about a buyout during the conference. He"s smarter than that but he has a job to do